This inventor holds 2 USPTO granted patents. Top assignee: United States of America as Represented by the Administrator of NASA. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: R Andrew McMillan: Innovator in Nanotechnology
Introduction
R Andrew McMillan is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of nanotechnology, holding 2 patents that showcase his innovative work. His research focuses on the development of biological nanostructures and versatile platforms for nanotechnology.
Latest Patents
McMillan's latest patents include "Ordered biological nanostructures formed from chaperonin polypeptides" and "Versatile platform for nanotechnology based on circular permutations of chaperonin protein." The first patent relates to nanotemplates, nanostructures, nanoarrays, and nanodevices formed from wild-type and mutated chaperonin polypeptides. It outlines methods for producing and utilizing these compositions. The second patent provides modified chaperonin polypeptides with relocated N-terminal and C-terminal ends, allowing for the assembly of double-ringed chaperonin structures. These structures can further organize into higher-order structures, such as nanofilaments or nanoarrays, which have applications in nanodevices and nanocoatings.
Career Highlights
McMillan works for the United States of America as represented by the Administrator of NASA. His role involves pioneering research in nanotechnology, contributing to advancements that have the potential to impact various scientific fields.
Collaborations
Some of his notable coworkers include Jonathan D Trent and Hiromi Kagawa. Their collaborative efforts have further enhanced the research and development of innovative nanotechnology solutions.
Conclusion
R Andrew McMillan is a key figure in the realm of nanotechnology, with a focus on chaperonin polypeptides and their applications. His patents reflect a commitment to advancing scientific knowledge and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile